Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

Clinical trial NCT06592599 · RECRUITING

Trial details

NCT number: NCT06592599
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2024-09-03
Primary completion: 2029-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.